TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biotec Pharmacon ASA
Closing information (x1000 EUR)
Closing information | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
Turnover | 8,557 | 7,260 | 7,394 |
Financial expenses | 82 | 0 | 71 |
Earnings before taxes | -601 | -1,379 | -2,521 |
Total assets | 7,869 | 6,781 | 6,269 |
Current assets | 5,941 | 5,570 | 5,078 |
Current liabilities | 1,862 | 1,408 | 1,714 |
Equity capital | 4,712 | 5,374 | 4,554 |
- share capital | 4,901 | 4,819 | 4,466 |
Employees (average) | 38 | 43 | 44 |
Shareholders | 0 | 0 | 0 |
Financial ratios
Fiscal year | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
Solvency | 59.9% | 79.3% | 72.6% |
Turnover per employee | 225 | 169 | 168 |
Profit as a percentage of turnover | -7.0% | -19.0% | -34.1% |
Return on assets (ROA) | -6.6% | -20.3% | -39.1% |
Current ratio | 319.1% | 395.6% | 296.3% |
Return on equity (ROE) | -12.8% | -25.7% | -55.4% |
Change turnover | 1,174 | 6 | -594 |
Change turnover % | 16% | 0% | -7% |
Chg. No. of employees | -5 | -1 | -2 |
Chg. No. of employees % | -12% | -2% | -4% |
Total value of public sale
Fiscal year | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.